Greenwich LifeSciences, Inc. Common Stock (GLSI) Stock
NASDAQ · GLSI
Key stats
- Market cap
- $236.17M
- Price / Earnings ratio
- -10.9x
- EPS (TTM)
- -$1.54
- Volume
- Loading
- 52-week high
- $34.10
- 52-week low
- $7.78
Source: third-party data provider, as of November 13, 2026
Compare with GLSI
Recent news

Stocktwits
Why Did Greenwich LifeSciences Stock Soar Pre-Market Today?
GLSIJanuary 22, 2026
Stocktwits
Why Did Greenwich LifeSciences Stock Soar Pre-Market Today?
GLSI

Stocktwits
Why Did GLSI Stock Surge 25% Today?
GLSIDecember 29, 2025
Stocktwits
Why Did GLSI Stock Surge 25% Today?
GLSI

Stocktwits
Why Is GLSI Stock Rising Today?
GLSIDecember 15, 2025
Stocktwits
Why Is GLSI Stock Rising Today?
GLSI

InvestorPlace
TOPS, SURG: The Top 5 Short Squeeze Stocks This Week
GLSIOctober 10, 2022
InvestorPlace
TOPS, SURG: The Top 5 Short Squeeze Stocks This Week
GLSI
Technical indicators
- RSI 14
- 48.45
- MACD 12/26/9
- -0.17
- EMA 9 of MACD
- -0.10
- MACD histogram
- -0.07
- SMA 50
- $16.59
- Price below SMA 50
- EMA 50
- $16.63
- Price below EMA 50
- SMA 200
- $21.13
- Price below SMA 200
- EMA 200
- $19.20
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
Revenue
Net income
Net margin %
2021
2022
2023
2024
2025
0000
Debt & Balance Sheet
Total assets
Total liabilities
2021
2022
2023
2024
2025
33M22M11M0
Revenue to Profit
2025$0.0
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$-19.4M
Net incomeEarnings
No data available
Source: third-party data provider
Latest news

Stocktwits
Why Did Greenwich LifeSciences Stock Soar Pre-Market Today?
GLSIJanuary 22, 2026
Stocktwits
Why Did Greenwich LifeSciences Stock Soar Pre-Market Today?
GLSI

Stocktwits
Why Did GLSI Stock Surge 25% Today?
GLSIDecember 29, 2025
Stocktwits
Why Did GLSI Stock Surge 25% Today?
GLSI

Stocktwits
Why Is GLSI Stock Rising Today?
GLSIDecember 15, 2025
Stocktwits
Why Is GLSI Stock Rising Today?
GLSI

InvestorPlace
TOPS, SURG: The Top 5 Short Squeeze Stocks This Week
GLSIOctober 10, 2022
InvestorPlace
TOPS, SURG: The Top 5 Short Squeeze Stocks This Week
GLSI

InvestorPlace
ATHX, PETS: The Top 5 Short Squeeze Stocks to Watch This Week
GLSISeptember 12, 2022
InvestorPlace
ATHX, PETS: The Top 5 Short Squeeze Stocks to Watch This Week
GLSI

InvestorPlace
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
GLSIApril 8, 2022
InvestorPlace
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
GLSI
About Greenwich LifeSciences, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees4
CEOMr. Snehal S. Patel
IPO DateSep 25, 2020
HeadquartersStafford, TX
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Snehal S. Patel | CEO, CFO & Director | 1964 |
| Mr. Eric Rothe | Founder & Independent Director | 1975 |
| Dr. Frank Joseph Daugherty M.D. | Chief Medical Officer & Director | 1951 |
| Dr. Jaye L. Thompson Ph.D. | Vice President Clinical & Regulatory Affairs | 1966 |
| Dr. Christine T. Fischette Ph.D. | VP of Business Development | 1951 |
Fundamentals
Valuation
Price-to-book value75.68
Profitability
Return on Equity-794.00%
Return on Assets-295.00%
EBITDA$-21.68M
Trading
Average volume136,042
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 48.45
- MACD 12/26/9
- -0.17
- EMA 9 of MACD
- -0.10
- MACD histogram
- -0.07
- SMA 50
- $16.59
- Price below SMA 50
- EMA 50
- $16.63
- Price below EMA 50
- SMA 200
- $21.13
- Price below SMA 200
- EMA 200
- $19.20
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -10.5 | -20.1 | ||||||||||
| 2022 | -21.7 | -5.8 | +0.3 | -39.1 | -30.5 | +16.0 | -9.7 | +21.4 | +3.8 | -5.7 | +51.3 | +8.6 |
| 2023 | +36.0 | -22.3 | -12.2 | -18.9 | -4.0 | -9.6 | -4.9 | -7.3 | -4.2 | -6.5 | +34.6 | -10.0 |
| 2024 | -20.0 | +36.8 | +53.4 | -34.8 | +5.9 | +23.4 | -3.9 | -9.5 | +7.0 | -3.0 | +6.0 | -24.9 |
| 2025 | +10.2 | -5.9 | -18.5 | +9.1 | -1.3 | -5.9 | +20.9 | +3.5 | -13.2 | -8.9 | +3.6 | +155.0 |
| 2026 | +54.4 | -13.3 | -12.3 | +2.9 | +10.5 | -17.7 | -43.0 | +10.4 | +20.3 | +0.3 | -2.2 |
Compare stocks
Market cap
$236.17M
-
-
-
Price / Earnings ratio
-10.90
-
-
-
Price / Sales ratio
-
-
-
Dividend yield
0.00%
-
-
-
Average volume
136,042
-
-
-
Earnings per share
$-1.54
-
-
-



